Идёт набор NCT07499674

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Фаза III С лечением Lung Cancer Lung Metastases

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: В протоколе указаны: Abenacianine, Near Infrared (NIR) Imaging.
Кому может быть актуально: Состояния в реестре: Lung Cancer, Lung Metastases. Базовые параметры: от 18 лет · Все.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: США, Австралия
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

A Phase 3, Multi-center, Randomized, Open Label Study to Evaluate the Safety and Efficacy of Abenacianine (VGT-309), a Tumor-Targeted, Activatable Fluorescent Imaging Agent, to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung - VISUALIZE 2

Обзор

This is a Phase 3, multi-center, randomized and intrasubject controlled study to evaluate the safety and efficacy of abenacianine for injection, a tumor-targeted, activatable fluorescent imaging agent, to identify cancer using NIR imaging in participants undergoing surgery for cancer in the lung. Approximately 132 partiipants will be enrolled to ensure a minimum of 115 evaluable participants receiving abenacianine and undergoing NIR imaging and a control group of 12 participants who will receive abenacianine but no NIR imaging.

Вмешательства

Препарат Abenacianine
Intravenous drug to be given by syringe pump.
Другое Near Infrared (NIR) Imaging
NIR imaging is a non-visible, optical technique capturing light just beyond human vision, allowing high-contrast imaging.

Первичные конечные точки

Identify the proportion of participants with at least one Clinically Significant Event (CSE) as defined by: [Срок оценки: Day of Surgery]

Вторичные конечные точки (4)

Key Secondary Endpoints [Срок оценки: Upon receipt of histopathology report (~2-3 weeks post surgery)]
Key Secondary [Срок оценки: Upon receipt of histopathology report. (~2-3 weeks post surgery)]
Key Secondary [Срок оценки: Upon receipt of histopathology report. (~2-3 weeks post surgery)]
Other Secondary Endpoints [Срок оценки: Day of surgery]

Критерии участия

Критерии включения

Be willing and able to sign the informed consent and comply with study procedures.
Be at least 18 years of age.
Be scheduled for or planning to have a surgical resection of a lung lesion or mass with diagnostic and/or curative intent.
Meet all requirements for the planned surgery based on opinion of the surgeon, anesthesiologist, and/or other consulting physician.
Be able to meet the following conditions:

Female participants must be of non-childbearing potential, or,
If of childbearing potential, be non-pregnant or non-lactating and agree to use highly effective contraception from screening through Day 30 after treatment.
Male participants, if not surgically sterilized, and if engaging in sexual intercourse with a female partner of childbearing potential, must be willing to use highly effective contraception from screening through 30 days after dosing.
Have not participated in an interventional clinical trial within the last 30 days.

Критерии исключения

They have a known allergy or reaction to radiographic contrast agents, ICG, or any component of abenacianine.
They have received chemotherapy, immunotherapy or radiotherapy within 4 weeks prior to study enrollment.
They have any other co-morbidity or habit that the Investigator believes will interfere with their ability to comply with and complete the study. They are not a candidate for standard of care surgery based on opinion of the surgeon, anesthesiologist, or other consulting physician.
They are prisoners, institutionalized individuals, or are unable to consent for themselves.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет